WANYI SCIENCE(SH:688600)2021-10-27 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥152,103,267.26, representing a 73.21% increase compared to the same period last year[5]. - The net profit attributable to shareholders for the same period was ¥3,793,696.66, with a year-to-date increase of 286.04% to ¥5,245,363.42[5]. - Total operating revenue for the first three quarters of 2021 reached ¥345,861,484.77, a significant increase from ¥225,161,269.20 in the same period of 2020, representing a growth of approximately 53.7%[18]. - The net profit for the third quarter of 2021 was ¥5,836,158.03, up from ¥2,066,228.39 in the same quarter of 2020, reflecting a growth of approximately 182.5%[19]. - The basic earnings per share for Q3 2021 were ¥0.03, with a year-to-date increase of 300% to ¥0.04[6]. - The basic earnings per share for the third quarter of 2021 were ¥0.04, compared to ¥0.01 in the same quarter of 2020, reflecting a 300% increase[20]. Research and Development - Research and development (R&D) expenses totaled ¥39,841,331.08 in Q3 2021, an increase of 108.64% year-on-year, accounting for 26.19% of operating revenue[6]. - Research and development expenses for the third quarter of 2021 amounted to ¥87,941,292.01, which is an increase of 85.5% compared to ¥47,393,571.87 in the same quarter of 2020[19]. - The company reported a significant increase in tax benefits from R&D investments, contributing to the net profit growth[10]. Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥1,146,061,576.36, reflecting an 11.68% increase from the end of the previous year[6]. - The total liabilities for the third quarter of 2021 were ¥327,510,702.00, compared to ¥185,793,973.74 in the same period of 2020, indicating an increase of about 76.1%[17]. - The total current assets are reported at ¥920,564,904.07, slightly down from ¥926,248,275.55 at the end of 2020[15]. - The total receivables from accounts receivable are reported at ¥104,330,702.99, down from ¥128,304,357.17 in the previous year[15]. Cash Flow - The cash flow from operating activities for the year-to-date period was negative at -¥48,749,066.27, primarily due to increased inventory for sales growth[6]. - The company’s cash flow from operating activities for the first three quarters of 2021 showed a positive trend, although specific figures were not disclosed in the provided content[22]. - The net cash flow from operating activities was negative at CNY -48,749,066.27, a decline from a positive CNY 4,049,520.35 in the first three quarters of 2020[23]. - The cash inflow from investment activities totaled CNY 911,459,582.51, significantly higher than CNY 306,978,425.55 in the previous year, marking an increase of 196.5%[24]. - The total cash and cash equivalents at the end of the period were CNY 73,666,375.95, a decrease from CNY 76,848,349.23 at the end of the same period in 2020[24]. Shareholder Information - The total number of shareholders at the end of the reporting period is 6,802[12]. - The largest shareholder, Zang Mu, holds 52,096,834 shares, representing 39.07% of the total shares[12]. - The total number of shares held by the top 10 shareholders includes 11,402,449 shares held by Anhui Chuangye Investment Co., accounting for 8.55%[13]. - The company has issued 1,667,000 restricted shares as part of its initial public offering, with a lock-up period of 24 months[13]. Inventory and Investments - Inventory has significantly increased to ¥296,415,961.32 from ¥116,717,596.77 in the previous year[15]. - The company has a long-term equity investment valued at ¥771,025.58, up from ¥254,954.76 in the previous year[15]. - The cash paid for purchasing fixed assets and other long-term assets was CNY 39,213,318.58, up from CNY 4,781,847.84 in the same period of 2020[24].